🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Deepak Rohila

Henry Ford Health System

ORCID: 0000-0001-7138-2702

Also affiliated with OPX Biotechnologies (United States), TriLink BioTechnologies (United States)

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma”.

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

Cancer Research(2023)10.1158/0008-5472.can-22-3645
N/A
0DataRank · unranked
45 citations

In Hwan Park, Timothy V. Pham, Jonathan Weitz, Tatiana Hurtado de Mendoza, Suresh Madheswaran +9 more

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1148317
N/A
0DataRank · unranked
19 citations

In Hwan Park, Timothy V. Pham, Riley N. Jones, Elisabette Tapia, Kevin X. Liu +5 more

NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models

Cancers(2023)10.3390/cancers15051468
N/A
0DataRank · unranked
6 citations

Álvaro de Mingo Pulido, Sheelu Varghese, Deepak Rohila, Daniel Hupalo, Yuriy Gusev +5 more

983 Syk promotes macrophage immunosuppressive phenotype to suppress anti-tumor immunity

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0983
N/A
0DataRank · unranked
0 citations

Suresh Madheswaran, Shweta Joshi, Deepak Rohila